{"gene":"GDF3","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1993,"finding":"GDF3 and GDF9 are novel members of the TGF-β superfamily, predicted to contain a signal sequence for secretion, a tetrabasic proteolytic processing site, and a C-terminal region homologous to known TGF-β superfamily members. Unlike all other superfamily members, GDF3 and GDF9 lack the conserved cysteine residue believed to form the intersubunit disulfide bond, suggesting different subunit interaction mechanisms.","method":"cDNA cloning, sequence analysis, Northern blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cDNA cloning with sequence analysis identifying novel structural features; single lab but foundational identification paper with multiple sequence analyses","pmids":["8429021"],"is_preprint":false},{"year":2005,"finding":"GDF3 inhibits BMP signaling in multiple developmental contexts and interacts physically with BMP proteins. GDF3 is expressed in the node during gastrulation consistent with a BMP-inhibitory role. Gain- and loss-of-function experiments show GDF3 regulates both maintenance of the undifferentiated state and differentiation capacity of embryonic stem cells in a species-specific manner.","method":"mRNA gain-of-function, reduction-of-function (antisense/RNAi), reporter assays, co-immunoprecipitation/interaction assay, in vivo Xenopus and mouse ES cell experiments","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (gain-of-function, loss-of-function, protein interaction, reporter assays) in multiple biological contexts; replicated aspects in subsequent publications","pmids":["16339188"],"is_preprint":false},{"year":2006,"finding":"GDF3 signals via the EGF-CFC co-receptor Cripto and can be inhibited by Lefty antagonists in cell culture, similar to Nodal. In Xenopus, GDF3 misexpression induces secondary axis formation and mesendoderm formation. In mice, Gdf3 null mutants show defects in anterior visceral endoderm formation and reduced Nodal expression, placing GDF3 in a Nodal-like signaling pathway.","method":"Cell-based reporter assays, Xenopus misexpression, mouse knockout analysis, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vitro signaling assay, in vivo Xenopus and mouse knockout), replicated in subsequent studies","pmids":["16368929"],"is_preprint":false},{"year":2007,"finding":"GDF3 signaling is mediated by type I receptor ALK4, type II receptors ActRIIA and ActRIIB, and co-receptor Cripto to activate Smad-dependent reporter genes. Native GDF3 precursor is poorly processed and inactive; activity can be unmasked by heterologous prodomains, co-expression with Furin pro-protein convertase, or co-expression with Nodal. GDF1 and GDF3 together represent functional mammalian homologs of Xenopus Vg1, as compound Gdf1/Gdf3 double-knockout mice show more severe AVE and mesoderm defects than either single mutant.","method":"Luciferase reporter assays, chimeric construct expression, Furin co-expression, genetic compound knockout analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro receptor identification with mutagenesis/chimeric constructs, Furin processing assay, and in vivo genetic epistasis via compound knockout","pmids":["17936261"],"is_preprint":false},{"year":2008,"finding":"GDF3 acts as a specific BMP inhibitor at physiological expression levels. BMP-inhibitory activity resides redundantly in both the unprocessed precursor form and the mature processed form of GDF3 protein. GDF3 can activate Nodal signaling only at very high (non-physiological) doses of mRNA overexpression, not as recombinant protein at normal doses.","method":"mRNA overexpression, recombinant protein treatment, dose-response reporter assays, Western blot for protein forms","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — systematic dose-response with both mRNA and recombinant protein, characterization of both precursor and mature forms; confirms and extends prior work","pmids":["18823971"],"is_preprint":false},{"year":2009,"finding":"Missense variants in GDF3 cause ocular (coloboma, microphthalmia) and skeletal (Klippel-Feil) anomalies in humans. Functional assessment using Western blot and luciferase reporter assays demonstrated appreciable effects of the variants. Antisense morpholino inhibition of zebrafish GDF3 co-ortholog recapitulates patient phenotypes, establishing GDF3 as necessary for ocular and skeletal development.","method":"Western blot, luciferase reporter assay, zebrafish antisense morpholino knockdown, patient variant characterization","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — integrated biochemical (Western blot, reporter assay) and in vivo zebrafish model with morpholino knockdown phenocopying patient phenotype","pmids":["19864492"],"is_preprint":false},{"year":2011,"finding":"GDF3 activates downstream signaling through associating with ALK7 (Activin receptor-like kinase 7) in a Cripto-dependent fashion. Secreted GDF3 protein from stable CHO-GDF3 cells reduces PC12 cell growth and induces neuronal differentiation. GDF3 protein is distributed mainly in the cytoplasm of expressing cells and in primary hippocampal neurons.","method":"Co-immunoprecipitation/receptor association assay, stable cell line conditioned medium treatment, immunofluorescence, Western blot","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 / Weak — single lab, receptor association shown but Cripto-dependence not fully characterized; conditioned medium experiment lacks direct protein quantification","pmids":["21805089"],"is_preprint":false},{"year":2012,"finding":"miR-483-3p targets GDF3 mRNA for translational repression in adipocytes. Manipulation of miR-483-3p levels substantially modulates adipocyte differentiation and lipid storage, with some effects mediated through GDF3 suppression.","method":"miRNA overexpression/knockdown in vitro, luciferase reporter assay for target validation, adipocyte differentiation assay","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — miRNA targeting of GDF3 validated with reporter assay and functional cellular readout; single lab, moderate mechanistic depth","pmids":["22223106"],"is_preprint":false},{"year":2016,"finding":"Macrophage PPARγ transcriptionally controls GDF3 expression in repair macrophages. GDF3 secreted by macrophages acts as an extrinsic effector on myoblasts to promote muscle progenitor cell fusion and skeletal muscle regeneration. PPARγ-null macrophages fail to upregulate GDF3, and this deficiency impairs muscle regeneration.","method":"Conditional macrophage-specific PPARγ knockout mice, muscle injury model, ChIP/transcriptional analysis, recombinant GDF3 treatment of myoblasts, fusion assay","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional knockout with defined cellular phenotype plus mechanistic identification of PPARγ as upstream regulator; replicated in subsequent studies","pmids":["27836432"],"is_preprint":false},{"year":2017,"finding":"Maternal (not zygotic) Gdf3 is required for mesendoderm formation and dorsal-ventral patterning in zebrafish. Gdf3 affects left-right patterning by regulating cell morphology in Kupffer's vesicle and southpaw expression in lateral plate mesoderm. Gdf3 maternal-zygotic mutants are refractory to Nodal ligands and Lefty1 repressor, but Activin signaling and constitutively active Alk4/Alk2 remain intact, placing Gdf3 at the same pathway step as Nodal.","method":"Maternal-zygotic mutant zebrafish, RNA rescue experiments, epistasis analysis with Nodal pathway components, morphological analysis of Kupffer's vesicle","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous maternal-zygotic mutant analysis with RNA rescue and pathway epistasis in multiple developmental stages; independently replicated by companion paper","pmids":["29140250"],"is_preprint":false},{"year":2017,"finding":"Gdf3 is an essential cofactor of Nodal signaling during embryonic axis establishment in zebrafish. Maternal-zygotic gdf3 mutants are fully rescued by gdf3 RNA only when co-expressed with endogenous Nodal, indicating Gdf3 acts cooperatively at the same step as Nodal ligands rather than independently. Signaling through constitutively active Alk4 and Alk2 is intact in gdf3 mutants, indicating that Gdf3 functions specifically at the Nodal pathway level.","method":"Maternal-zygotic mutant zebrafish, lineage-specific RNA targeting rescue experiments, constitutively active receptor epistasis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous genetic rescue experiments with lineage-specific targeting, epistasis analysis; independently replicated by companion paper (PMID 29140250)","pmids":["29140249"],"is_preprint":false},{"year":2018,"finding":"In aged mice, repair macrophage-derived GDF3 is markedly downregulated in injured muscle compared to young mice. Supplementation of recombinant GDF3 in aged mice ameliorates the deficient regenerative response, establishing that macrophage-secreted GDF3 is functionally limiting for muscle regeneration during aging.","method":"Aged vs. young mouse muscle injury model, flow cytometry for macrophage subsets, recombinant GDF3 administration, histological analysis of regeneration","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo recombinant protein rescue experiment with defined cellular readout; single lab extending prior mechanistic work","pmids":["30003692"],"is_preprint":false},{"year":2020,"finding":"GDF3 activates Smad2/Smad3 phosphorylation in macrophages and consequently inhibits NLRP3 expression, mediating anti-inflammatory effects. Recombinant GDF3 suppresses macrophage pro-inflammatory (M1) phenotype and promotes anti-inflammatory (M2) polarization. Blockade of Smad2/Smad3 phosphorylation with SB431542 offsets rGDF3-mediated anti-inflammatory effects.","method":"Recombinant GDF3 protein treatment of macrophages, Western blot for pSmad2/3, NLRP3 expression assay, pharmacological inhibition of Smad2/3 with SB431542, in vivo endotoxemia mouse model","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological epistasis linking GDF3 to Smad2/3-NLRP3 axis, supported by in vivo rescue; single lab","pmids":["31947892"],"is_preprint":false},{"year":2021,"finding":"Brd4 binds to the promoter and enhancers of Gdf3 to facilitate PPARγ-dependent Gdf3 expression in macrophages. Macrophage-derived GDF3 acts as a paracrine signal on adipocytes to suppress lipase expression (ATGL, HSL) and inhibit lipolysis. Myeloid-specific Brd4 knockout reduces GDF3 in adipose tissue macrophages and increases lipolysis.","method":"ChIP-seq (Brd4 at Gdf3 locus), myeloid-specific Brd4 knockout mice, RNA-seq of adipose tissue macrophages, co-culture/conditioned medium experiments, Western blot for lipases","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq demonstrating direct Brd4 binding to Gdf3 locus, in vivo conditional knockout, and paracrine functional assay; multiple orthogonal methods","pmids":["33830083"],"is_preprint":false},{"year":2021,"finding":"Recombinant GDF3 promotes macrophage phagocytosis and intracellular bacterial killing by promoting LXRα nuclear translocation. RNA-seq identified CD5L (regulated by LXRα) as the most significantly upregulated gene in rGDF3-treated macrophages. GDF3 failed to enhance bacterial uptake or killing in LXRα-knockout macrophages, placing LXRα downstream of GDF3 in this pathway.","method":"Recombinant GDF3 treatment of macrophages, RNA-seq, LXRα nuclear translocation assay, LXRα knockout macrophages, bacterial phagocytosis/killing assay, pharmacological LXRα antagonism","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (LXRα KO) and pharmacological epistasis with functional phagocytosis readout; single lab","pmids":["33679812"],"is_preprint":false},{"year":2022,"finding":"GDF3 secreted by cardiac stromal PW1+ cells induces fibroblast proliferation via stimulation of activin-receptor-like kinases. GDF3 is markedly upregulated in ischemic hearts post-MI and detectable in plasma, implicating it as a paracrine cardiokine promoting adverse fibrotic remodeling.","method":"Secretome bioinformatic analysis, conditioned medium fibroblast proliferation assay, GDF3-enriched conditioned medium functional assay, activin receptor kinase pharmacological inhibition, mouse and human plasma GDF3 measurement","journal":"Circulation","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — conditioned medium functional assay with receptor pharmacological epistasis; mechanistic depth is partial (receptor identity inferred from pharmacology, not genetic knockdown)","pmids":["36484260"],"is_preprint":false},{"year":2025,"finding":"GDF3 is an agonist of ALK5, ALK7, ACVR2A, and ACVR2B, and an antagonist of BMPR2. Inducible GDF3 loss-of-function in obese mice reduces lipolysis by lowering β3-adrenergic receptor levels and decreasing cAMP/PKA signaling. GDF3 loss improves glucose tolerance and reduces glycemic variability without affecting body weight or energy balance.","method":"Inducible conditional knockout in adult obese mice, receptor signaling assays (ALK5/ALK7/ACVR2A/ACVR2B/BMPR2 activity), metabolic phenotyping (glucose tolerance, lipolysis, β3-AR/cAMP/PKA measurements)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo conditional knockout with multiple receptor identity assays and defined downstream signaling (β3-AR/cAMP/PKA); multiple orthogonal functional readouts","pmids":["40360531"],"is_preprint":false},{"year":2025,"finding":"GDF3 promotes the inflammatory phenotype in adipose tissue macrophages through autocrine GDF3-SMAD2/3 signaling, driving chromatin accessibility toward an inflammatory state by limiting methylation-dependent chromatin compaction. Lifelong systemic or myeloid-specific Gdf3 deletion reduces endotoxemia-induced inflammation. Pharmacological inhibition of SMAD3 with SIS3 mimics Gdf3 deletion and reduces mortality from endotoxemia in old mice.","method":"Systemic and myeloid-specific Gdf3 knockout mice, scRNA-seq, ATAC-seq of ATMs, SMAD3 pharmacological inhibition (SIS3), BRD4 inhibitor (JQ1) treatment, endotoxemia mortality assay","journal":"Nature aging","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (systemic KO, myeloid-specific KO), ATAC-seq mechanistic chromatin data, pharmacological epistasis, validated in human tissue; multiple orthogonal methods in single study","pmids":["41398392"],"is_preprint":false}],"current_model":"GDF3 is a secreted TGF-β superfamily member that functions as a BMP inhibitor (acting via its unprocessed and mature forms), an essential cofactor for Nodal signaling during embryonic axis formation (requiring Cripto co-receptor and signaling through ALK4/ALK7, ActRIIA/ActRIIB), and a pleiotropic cytokine in adult tissues where macrophage-derived GDF3 drives SMAD2/3-dependent regulation of muscle regeneration, adipose tissue lipolysis (via ALK5/ALK7/ACVR2A/ACVR2B agonism and BMPR2 antagonism suppressing β3-AR/cAMP/PKA signaling), and macrophage inflammatory phenotype by promoting chromatin accessibility toward an inflammatory state; its expression in macrophages is transcriptionally controlled upstream by PPARγ and Brd4."},"narrative":{"mechanistic_narrative":"GDF3 is a secreted TGF-β superfamily ligand that operates dually as a Nodal-pathway cofactor in embryonic axis formation and as a BMP inhibitor, with distinct pleiotropic roles in adult macrophages [PMID:8429021, PMID:16339188, PMID:16368929]. During development, GDF3 antagonizes BMP signaling through both its poorly processed precursor and its mature form [PMID:16339188, PMID:18823971], and—acting cooperatively at the same pathway step as Nodal ligands rather than independently—signals through the EGF-CFC co-receptor Cripto and the type I/II receptors ALK4, ActRIIA and ActRIIB to drive Smad-dependent transcription [PMID:16368929, PMID:17936261, PMID:29140249]. The native precursor is largely inactive until processed, an activity unmasked by Furin co-expression or heterologous prodomains [PMID:17936261]. Together with GDF1, GDF3 is required for anterior visceral endoderm formation, mesendoderm specification, and left-right patterning, with maternal Gdf3 acting upstream of Nodal-dependent events [PMID:17936261, PMID:29140250, PMID:29140249]. In adults, macrophage-derived GDF3 is a paracrine and autocrine cytokine: PPARγ and Brd4 drive its transcription in repair and adipose tissue macrophages [PMID:27836432, PMID:33830083], and secreted GDF3 promotes muscle progenitor fusion and regeneration—an output that becomes limiting with age [PMID:27836432, PMID:30003692]. Through SMAD2/3 signaling GDF3 suppresses adipocyte lipase expression and lipolysis, lowering β3-adrenergic receptor and cAMP/PKA signaling, and acts as an agonist of ALK5, ALK7, ACVR2A and ACVR2B while antagonizing BMPR2 [PMID:33830083, PMID:40360531]. Autocrine GDF3-SMAD2/3 signaling drives an inflammatory macrophage state by increasing chromatin accessibility, and its loss reduces endotoxemia-induced inflammation [PMID:41398392]. Missense variants in GDF3 cause human ocular (coloboma, microphthalmia) and skeletal (Klippel-Feil) anomalies [PMID:19864492].","teleology":[{"year":1993,"claim":"Establishing GDF3 as a TGF-β superfamily member defined the structural framework—signal sequence, proteolytic processing site, and an atypical absence of the conserved intersubunit cysteine—for all later functional studies.","evidence":"cDNA cloning, sequence analysis, and Northern blot","pmids":["8429021"],"confidence":"Medium","gaps":["No functional activity or receptor assigned","Consequences of the missing intersubunit cysteine for dimerization not tested","Tissue distribution of activity unknown"]},{"year":2005,"claim":"Identifying GDF3 as a physical BMP-interacting inhibitor expressed in the node established its first concrete mechanistic role in developmental patterning and stem cell state.","evidence":"Gain/loss-of-function, reporter assays, and co-IP in Xenopus and mouse ES cells","pmids":["16339188"],"confidence":"High","gaps":["Which BMP ligands are bound was not exhaustively mapped","Did not reconcile BMP-inhibitory with Nodal-like activity","Species-specific ES cell effects unexplained"]},{"year":2006,"claim":"Showing GDF3 signals via Cripto and is blocked by Lefty, like Nodal, and that Gdf3-null mice have AVE defects with reduced Nodal, placed GDF3 within the Nodal signaling pathway.","evidence":"Cell reporter assays, Xenopus misexpression, mouse knockout, in situ hybridization","pmids":["16368929"],"confidence":"High","gaps":["Type I/II receptor identity not resolved here","Relationship between Nodal-like and BMP-inhibitory activities unclear","Whether GDF3 signals as a ligand or cofactor unresolved"]},{"year":2007,"claim":"Defining ALK4/ActRIIA/ActRIIB/Cripto as the receptor module and demonstrating that the poorly-processed precursor requires Furin or prodomain swap to activate explained why native GDF3 has weak activity and unified it with GDF1 as a Vg1 homolog.","evidence":"Luciferase reporters, chimeric/Furin co-expression, Gdf1/Gdf3 compound knockout","pmids":["17936261"],"confidence":"High","gaps":["Physiological processing trigger in vivo not identified","Quantitative contribution of GDF1 vs GDF3 not separated","Mature dimer structure not determined"]},{"year":2008,"claim":"Resolving that BMP inhibition occurs at physiological doses via both precursor and mature forms, while Nodal activation requires non-physiological overexpression, clarified GDF3's predominant in vivo activity.","evidence":"mRNA vs recombinant protein dose-response reporter assays, Western blot of protein forms","pmids":["18823971"],"confidence":"High","gaps":["Context determining BMP-inhibition vs Nodal-cofactor role unclear","Mechanism by which the precursor inhibits BMP not defined","In vivo dose dependence not directly measured"]},{"year":2009,"claim":"Linking GDF3 missense variants to human ocular and skeletal malformations, with zebrafish knockdown phenocopy, established GDF3 as necessary for human eye and axial skeletal development.","evidence":"Patient variant Western blot/reporter assays and zebrafish morpholino knockdown","pmids":["19864492"],"confidence":"High","gaps":["Mechanism linking signaling defect to specific malformations not detailed","Penetrance and genotype-phenotype correlation limited","Morpholino specificity caveats"]},{"year":2011,"claim":"Demonstrating ALK7 association in a Cripto-dependent manner and GDF3-driven neuronal differentiation extended its receptor repertoire and suggested non-developmental cellular effects.","evidence":"Co-IP receptor association, conditioned medium on PC12/neurons, immunofluorescence","pmids":["21805089"],"confidence":"Medium","gaps":["Cripto-dependence not fully characterized","Conditioned medium lacked protein quantification","Physiological relevance of neuronal effect untested in vivo"]},{"year":2012,"claim":"Identifying miR-483-3p as a translational repressor of GDF3 revealed post-transcriptional control of GDF3 in adipocyte differentiation and lipid storage.","evidence":"miRNA overexpression/knockdown, luciferase target validation, adipocyte assays","pmids":["22223106"],"confidence":"Medium","gaps":["Fraction of phenotype attributable to GDF3 vs other targets unclear","In vivo regulation not demonstrated","Downstream signaling not mapped"]},{"year":2016,"claim":"Showing PPARγ transcriptionally drives macrophage GDF3, which acts on myoblasts to promote fusion and regeneration, established GDF3 as a macrophage-derived effector of tissue repair.","evidence":"Macrophage-specific PPARγ knockout, muscle injury model, recombinant GDF3 fusion assay","pmids":["27836432"],"confidence":"High","gaps":["Receptor on myoblasts not identified here","Direct vs indirect fusion mechanism unresolved","Whether developmental and repair pathways share components unknown"]},{"year":2018,"claim":"Demonstrating that macrophage GDF3 declines with age and that recombinant supplementation restores regeneration established GDF3 as a functionally limiting factor in aged muscle repair.","evidence":"Aged vs young muscle injury, macrophage flow cytometry, recombinant GDF3 rescue","pmids":["30003692"],"confidence":"Medium","gaps":["Cause of age-related downregulation not identified","Single-lab extension of prior work","Receptor/signaling in aged myoblasts not dissected"]},{"year":2020,"claim":"Linking GDF3 to Smad2/3-dependent NLRP3 suppression and M2 polarization defined a signaling axis for its anti-inflammatory macrophage effects.","evidence":"Recombinant GDF3, pSmad2/3 Western, NLRP3 assays, SB431542 inhibition, endotoxemia model","pmids":["31947892"],"confidence":"Medium","gaps":["Anti-inflammatory effect here conflicts with later pro-inflammatory role","Specific receptor mediating Smad2/3 in macrophages not defined","Single lab"]},{"year":2021,"claim":"Identifying Brd4 binding at the Gdf3 locus to enable PPARγ-dependent expression, and the resulting paracrine suppression of adipocyte lipases, mapped both upstream control and a metabolic output of macrophage GDF3.","evidence":"ChIP-seq, myeloid Brd4 knockout, RNA-seq, conditioned medium, lipase Westerns","pmids":["33830083"],"confidence":"High","gaps":["Adipocyte receptor mediating lipase suppression not pinpointed here","Relationship between PPARγ and Brd4 cooperativity not fully defined","Systemic metabolic consequences not yet tested"]},{"year":2021,"claim":"Placing LXRα/CD5L downstream of GDF3 in promoting macrophage phagocytosis and bacterial killing identified a distinct antimicrobial effector arm.","evidence":"Recombinant GDF3, RNA-seq, LXRα translocation, LXRα knockout, phagocytosis assays","pmids":["33679812"],"confidence":"Medium","gaps":["Receptor coupling GDF3 to LXRα not defined","In vivo infection relevance limited","Single lab"]},{"year":2022,"claim":"Showing cardiac PW1+ cell-derived GDF3 drives fibroblast proliferation via activin-like kinases after infarction extended its paracrine role to adverse cardiac fibrotic remodeling.","evidence":"Secretome analysis, conditioned medium proliferation, receptor pharmacology, plasma GDF3","pmids":["36484260"],"confidence":"Medium","gaps":["Receptor identity inferred pharmacologically, not by genetic knockdown","Causal in vivo role of cardiac GDF3 not established by loss-of-function","Single lab"]},{"year":2025,"claim":"Defining GDF3 as an ALK5/ALK7/ACVR2A/ACVR2B agonist and BMPR2 antagonist, and showing inducible loss reduces lipolysis via β3-AR/cAMP/PKA while improving glucose tolerance, provided the adult receptor logic and metabolic consequences of GDF3 signaling.","evidence":"Inducible conditional knockout in obese mice, receptor signaling assays, metabolic phenotyping","pmids":["40360531"],"confidence":"High","gaps":["How agonist/antagonist activities are balanced on individual cells unclear","Tissue source of the active GDF3 in this context not fully resolved","Human translatability untested"]},{"year":2025,"claim":"Demonstrating that autocrine GDF3-SMAD2/3 signaling drives an inflammatory macrophage state through increased chromatin accessibility, and that Gdf3 deletion or SMAD3 inhibition reduces endotoxemia, reframed GDF3 as a pro-inflammatory chromatin regulator in aging.","evidence":"Systemic/myeloid Gdf3 knockout, scRNA-seq, ATAC-seq, SIS3 and JQ1 treatment, endotoxemia mortality","pmids":["41398392"],"confidence":"High","gaps":["Reconciliation with the earlier anti-inflammatory/NLRP3-suppressive report needed","Molecular link between SMAD2/3 and chromatin compaction machinery not fully defined","Receptor mediating autocrine signaling not specified"]},{"year":null,"claim":"It remains unknown what determines the context-dependent switch between GDF3's BMP-inhibitory, Nodal-cofactor, and SMAD2/3-agonist activities, and how the same ligand produces opposing pro- and anti-inflammatory outcomes in macrophages.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model reconciles agonist vs inhibitor behavior across tissues","Structural basis of GDF3 dimerization and receptor selectivity undefined","In vivo processing/activation triggers not identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[2,3,6,16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,16]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,12,16]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,6,8,13,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,12,16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,2,3,5,9,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[12,14,17]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,13,16]}],"complexes":[],"partners":["TDGF1","ACVR1B","ACVR2A","ACVR2B","ACVR1C","TGFBR1","BMPR2","BMP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NR23","full_name":"Growth/differentiation factor 3","aliases":[],"length_aa":364,"mass_kda":41.4,"function":"Growth factor involved in early embryonic development and adipose-tissue homeostasis. During embryogenesis controls formation of anterior visceral endoderm and mesoderm and the establishment of anterior-posterior identity through a receptor complex comprising the receptor ACVR1B and the coreceptor CRIPTO (By similarity). Regulates adipose-tissue homeostasis and energy balance under nutrient overload in part by signaling through the receptor complex based on ACVR1C and CRIPTO/Cripto (PubMed:21805089)","subcellular_location":"Secreted; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9NR23/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GDF3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GDF3","total_profiled":1310},"omim":[{"mim_id":"613704","title":"MICROPHTHALMIA, ISOLATED 7; MCOP7","url":"https://www.omim.org/entry/613704"},{"mim_id":"613703","title":"MICROPHTHALMIA/COLOBOMA 6; MCOPCB6","url":"https://www.omim.org/entry/613703"},{"mim_id":"613702","title":"KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3","url":"https://www.omim.org/entry/613702"},{"mim_id":"608981","title":"ACTIVIN A RECEPTOR, TYPE IC; ACVR1C","url":"https://www.omim.org/entry/608981"},{"mim_id":"607937","title":"NANOG HOMEOBOX; NANOG","url":"https://www.omim.org/entry/607937"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"kidney","ntpm":4.3}],"url":"https://www.proteinatlas.org/search/GDF3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9NR23","domains":[{"cath_id":"2.10.90.10","chopping":"37-77_257-364","consensus_level":"medium","plddt":88.4847,"start":37,"end":364},{"cath_id":"-","chopping":"83-239","consensus_level":"high","plddt":84.9499,"start":83,"end":239}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR23","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR23-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR23-F1-predicted_aligned_error_v6.png","plddt_mean":82.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GDF3","jax_strain_url":"https://www.jax.org/strain/search?query=GDF3"},"sequence":{"accession":"Q9NR23","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NR23.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NR23/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR23"}},"corpus_meta":[{"pmid":"16228988","id":"PMC_16228988","title":"Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma.","date":"2005","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16228988","citation_count":348,"is_preprint":false},{"pmid":"8429021","id":"PMC_8429021","title":"GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8429021","citation_count":232,"is_preprint":false},{"pmid":"14990856","id":"PMC_14990856","title":"Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma.","date":"2004","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/14990856","citation_count":180,"is_preprint":false},{"pmid":"27836432","id":"PMC_27836432","title":"Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27836432","citation_count":162,"is_preprint":false},{"pmid":"16339188","id":"PMC_16339188","title":"GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16339188","citation_count":131,"is_preprint":false},{"pmid":"16368929","id":"PMC_16368929","title":"The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16368929","citation_count":127,"is_preprint":false},{"pmid":"19864492","id":"PMC_19864492","title":"Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomalies.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19864492","citation_count":121,"is_preprint":false},{"pmid":"22223106","id":"PMC_22223106","title":"Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22223106","citation_count":116,"is_preprint":false},{"pmid":"22729946","id":"PMC_22729946","title":"Enhanced red emission from GdF3:Yb3+,Er3+ upconversion nanocrystals by Li+ doping and their application for bioimaging.","date":"2012","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/22729946","citation_count":81,"is_preprint":false},{"pmid":"17936261","id":"PMC_17936261","title":"Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17936261","citation_count":77,"is_preprint":false},{"pmid":"31947892","id":"PMC_31947892","title":"GDF3 Protects Mice against Sepsis-Induced Cardiac Dysfunction and Mortality by Suppression of Macrophage Pro-Inflammatory Phenotype.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31947892","citation_count":58,"is_preprint":false},{"pmid":"19396148","id":"PMC_19396148","title":"Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.","date":"2009","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/19396148","citation_count":58,"is_preprint":false},{"pmid":"29140250","id":"PMC_29140250","title":"Gdf3 is required for robust Nodal signaling during germ layer formation and left-right patterning.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29140250","citation_count":53,"is_preprint":false},{"pmid":"16721050","id":"PMC_16721050","title":"GDF3 at the crossroads of TGF-beta signaling.","date":"2006","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16721050","citation_count":43,"is_preprint":false},{"pmid":"23117700","id":"PMC_23117700","title":"PEG-capped, lanthanide doped GdF3 nanoparticles: luminescent and T2 contrast agents for optical and MRI multimodal imaging.","date":"2012","source":"Nanoscale","url":"https://pubmed.ncbi.nlm.nih.gov/23117700","citation_count":41,"is_preprint":false},{"pmid":"29140249","id":"PMC_29140249","title":"Maternal Gdf3 is an obligatory cofactor in Nodal signaling for embryonic axis formation in zebrafish.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29140249","citation_count":40,"is_preprint":false},{"pmid":"18823971","id":"PMC_18823971","title":"GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18823971","citation_count":36,"is_preprint":false},{"pmid":"15358131","id":"PMC_15358131","title":"GDF-3 is an adipogenic cytokine under high fat dietary condition.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15358131","citation_count":33,"is_preprint":false},{"pmid":"33830083","id":"PMC_33830083","title":"Brd4 modulates diet-induced obesity via PPARγ-dependent Gdf3 expression in adipose tissue macrophages.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33830083","citation_count":29,"is_preprint":false},{"pmid":"30003692","id":"PMC_30003692","title":"In vivo GDF3 administration abrogates aging related muscle regeneration delay following acute sterile injury.","date":"2018","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/30003692","citation_count":27,"is_preprint":false},{"pmid":"36484260","id":"PMC_36484260","title":"Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction.","date":"2022","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/36484260","citation_count":23,"is_preprint":false},{"pmid":"20950440","id":"PMC_20950440","title":"An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma.","date":"2010","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/20950440","citation_count":17,"is_preprint":false},{"pmid":"33155818","id":"PMC_33155818","title":"Multifunctional Transferrin Encapsulated GdF3 Nanoparticles for Sentinel Lymph Node and Tumor Imaging.","date":"2020","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33155818","citation_count":15,"is_preprint":false},{"pmid":"22488170","id":"PMC_22488170","title":"GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol.","date":"2012","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22488170","citation_count":14,"is_preprint":false},{"pmid":"33679812","id":"PMC_33679812","title":"Administration of GDF3 Into Septic Mice Improves Survival via Enhancing LXRα-Mediated Macrophage Phagocytosis.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33679812","citation_count":13,"is_preprint":false},{"pmid":"25140354","id":"PMC_25140354","title":"GdF3 as a promising phosphopeptide affinity probe and dephospho-labelling medium: experiments and theoretical explanation.","date":"2014","source":"Chemical communications (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25140354","citation_count":11,"is_preprint":false},{"pmid":"21805089","id":"PMC_21805089","title":"The conditioned medium from a stable human GDF3-expressing CHO cell line, induces the differentiation of PC12 cells.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21805089","citation_count":11,"is_preprint":false},{"pmid":"22522086","id":"PMC_22522086","title":"Klippel-Feil syndrome associated with situs inversus: description of a new case and exclusion of GDF1, GDF3 and GDF6 as causal genes.","date":"2012","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22522086","citation_count":11,"is_preprint":false},{"pmid":"25372014","id":"PMC_25372014","title":"A novel variation of GDF3 in Chinese Han children with a broad phenotypic spectrum of non-syndromic CHDs.","date":"2014","source":"Cardiology in the young","url":"https://pubmed.ncbi.nlm.nih.gov/25372014","citation_count":5,"is_preprint":false},{"pmid":"30206386","id":"PMC_30206386","title":"Phylogenetic evidence for independent origins of GDF1 and GDF3 genes in anurans and mammals.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30206386","citation_count":5,"is_preprint":false},{"pmid":"34755752","id":"PMC_34755752","title":"Multimodal fluorescently labeled polymer-coated GdF3 nanoparticles inhibit degranulation in mast cells.","date":"2021","source":"Nanoscale","url":"https://pubmed.ncbi.nlm.nih.gov/34755752","citation_count":5,"is_preprint":false},{"pmid":"41398392","id":"PMC_41398392","title":"GDF3 promotes adipose tissue macrophage-mediated inflammation via altered chromatin accessibility during aging.","date":"2025","source":"Nature aging","url":"https://pubmed.ncbi.nlm.nih.gov/41398392","citation_count":4,"is_preprint":false},{"pmid":"29735971","id":"PMC_29735971","title":"Functional and In Silico Assessment of GDF3 Gene Variants in a Chinese Congenital Scoliosis Population.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/29735971","citation_count":4,"is_preprint":false},{"pmid":"39662098","id":"PMC_39662098","title":"Total saponins from Panax japonicus mediate the paracrine interaction between adipocytes and macrophages to promote lipolysis in the adipose tissue during aging via the NLRP3 inflammasome/GDF3/ATGL axis.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39662098","citation_count":4,"is_preprint":false},{"pmid":"29260090","id":"PMC_29260090","title":"A recurrent, non-penetrant sequence variant, p.Arg266Cys in Growth/Differentiation Factor 3 (GDF3) in a female with unilateral anophthalmia and skeletal anomalies.","date":"2017","source":"American journal of ophthalmology case reports","url":"https://pubmed.ncbi.nlm.nih.gov/29260090","citation_count":4,"is_preprint":false},{"pmid":"40360531","id":"PMC_40360531","title":"Acute regulation of murine adipose tissue lipolysis and insulin resistance by the TGFβ superfamily protein GDF3.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40360531","citation_count":3,"is_preprint":false},{"pmid":"35632746","id":"PMC_35632746","title":"Increased Serum Levels of Growth-Differentiation Factor 3 (GDF3) and Inflammasome-Related Markers in Pregnant Women during Acute Zika Virus Infection.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/35632746","citation_count":3,"is_preprint":false},{"pmid":"39386655","id":"PMC_39386655","title":"GDF3 promotes adipose tissue macrophage-mediated inflammation via altered chromatin accessibility during aging.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39386655","citation_count":2,"is_preprint":false},{"pmid":"38543054","id":"PMC_38543054","title":"GDF3 Protects Mice against Sepsis-Induced Acute Lung Injury by Suppression of Macrophage Pyroptosis.","date":"2024","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38543054","citation_count":2,"is_preprint":false},{"pmid":"37081691","id":"PMC_37081691","title":"The GDF3-ALK7 signaling axis in adipose tissue: a possible therapeutic target for obesity and associated diabetes?","date":"2023","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/37081691","citation_count":2,"is_preprint":false},{"pmid":"38248673","id":"PMC_38248673","title":"Temperature Sensing Properties of Biocompatible Yb/Er-Doped GdF3 and YF3 Mesocrystals.","date":"2023","source":"Journal of functional biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/38248673","citation_count":2,"is_preprint":false},{"pmid":"35477223","id":"PMC_35477223","title":"Secreted key regulators (Fgf1, Bmp4, Gdf3) are expressed by PAC1-immunopositive retinal ganglion cells in the postnatal rat retina.","date":"2022","source":"European journal of histochemistry : EJH","url":"https://pubmed.ncbi.nlm.nih.gov/35477223","citation_count":1,"is_preprint":false},{"pmid":"38639949","id":"PMC_38639949","title":"[Expression and significance analysis of GDF3 in testicular cancer based on TCGA and GTEx databases].","date":"2023","source":"Zhonghua nan ke xue = National journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/38639949","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21432,"output_tokens":4975,"usd":0.06946,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13435,"output_tokens":5467,"usd":0.101925,"stage2_stop_reason":"end_turn"},"total_usd":0.171385,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GDF3 and GDF9 are novel members of the TGF-β superfamily, predicted to contain a signal sequence for secretion, a tetrabasic proteolytic processing site, and a C-terminal region homologous to known TGF-β superfamily members. Unlike all other superfamily members, GDF3 and GDF9 lack the conserved cysteine residue believed to form the intersubunit disulfide bond, suggesting different subunit interaction mechanisms.\",\n      \"method\": \"cDNA cloning, sequence analysis, Northern blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cDNA cloning with sequence analysis identifying novel structural features; single lab but foundational identification paper with multiple sequence analyses\",\n      \"pmids\": [\"8429021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GDF3 inhibits BMP signaling in multiple developmental contexts and interacts physically with BMP proteins. GDF3 is expressed in the node during gastrulation consistent with a BMP-inhibitory role. Gain- and loss-of-function experiments show GDF3 regulates both maintenance of the undifferentiated state and differentiation capacity of embryonic stem cells in a species-specific manner.\",\n      \"method\": \"mRNA gain-of-function, reduction-of-function (antisense/RNAi), reporter assays, co-immunoprecipitation/interaction assay, in vivo Xenopus and mouse ES cell experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (gain-of-function, loss-of-function, protein interaction, reporter assays) in multiple biological contexts; replicated aspects in subsequent publications\",\n      \"pmids\": [\"16339188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GDF3 signals via the EGF-CFC co-receptor Cripto and can be inhibited by Lefty antagonists in cell culture, similar to Nodal. In Xenopus, GDF3 misexpression induces secondary axis formation and mesendoderm formation. In mice, Gdf3 null mutants show defects in anterior visceral endoderm formation and reduced Nodal expression, placing GDF3 in a Nodal-like signaling pathway.\",\n      \"method\": \"Cell-based reporter assays, Xenopus misexpression, mouse knockout analysis, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vitro signaling assay, in vivo Xenopus and mouse knockout), replicated in subsequent studies\",\n      \"pmids\": [\"16368929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GDF3 signaling is mediated by type I receptor ALK4, type II receptors ActRIIA and ActRIIB, and co-receptor Cripto to activate Smad-dependent reporter genes. Native GDF3 precursor is poorly processed and inactive; activity can be unmasked by heterologous prodomains, co-expression with Furin pro-protein convertase, or co-expression with Nodal. GDF1 and GDF3 together represent functional mammalian homologs of Xenopus Vg1, as compound Gdf1/Gdf3 double-knockout mice show more severe AVE and mesoderm defects than either single mutant.\",\n      \"method\": \"Luciferase reporter assays, chimeric construct expression, Furin co-expression, genetic compound knockout analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro receptor identification with mutagenesis/chimeric constructs, Furin processing assay, and in vivo genetic epistasis via compound knockout\",\n      \"pmids\": [\"17936261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GDF3 acts as a specific BMP inhibitor at physiological expression levels. BMP-inhibitory activity resides redundantly in both the unprocessed precursor form and the mature processed form of GDF3 protein. GDF3 can activate Nodal signaling only at very high (non-physiological) doses of mRNA overexpression, not as recombinant protein at normal doses.\",\n      \"method\": \"mRNA overexpression, recombinant protein treatment, dose-response reporter assays, Western blot for protein forms\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — systematic dose-response with both mRNA and recombinant protein, characterization of both precursor and mature forms; confirms and extends prior work\",\n      \"pmids\": [\"18823971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Missense variants in GDF3 cause ocular (coloboma, microphthalmia) and skeletal (Klippel-Feil) anomalies in humans. Functional assessment using Western blot and luciferase reporter assays demonstrated appreciable effects of the variants. Antisense morpholino inhibition of zebrafish GDF3 co-ortholog recapitulates patient phenotypes, establishing GDF3 as necessary for ocular and skeletal development.\",\n      \"method\": \"Western blot, luciferase reporter assay, zebrafish antisense morpholino knockdown, patient variant characterization\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — integrated biochemical (Western blot, reporter assay) and in vivo zebrafish model with morpholino knockdown phenocopying patient phenotype\",\n      \"pmids\": [\"19864492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GDF3 activates downstream signaling through associating with ALK7 (Activin receptor-like kinase 7) in a Cripto-dependent fashion. Secreted GDF3 protein from stable CHO-GDF3 cells reduces PC12 cell growth and induces neuronal differentiation. GDF3 protein is distributed mainly in the cytoplasm of expressing cells and in primary hippocampal neurons.\",\n      \"method\": \"Co-immunoprecipitation/receptor association assay, stable cell line conditioned medium treatment, immunofluorescence, Western blot\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Weak — single lab, receptor association shown but Cripto-dependence not fully characterized; conditioned medium experiment lacks direct protein quantification\",\n      \"pmids\": [\"21805089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"miR-483-3p targets GDF3 mRNA for translational repression in adipocytes. Manipulation of miR-483-3p levels substantially modulates adipocyte differentiation and lipid storage, with some effects mediated through GDF3 suppression.\",\n      \"method\": \"miRNA overexpression/knockdown in vitro, luciferase reporter assay for target validation, adipocyte differentiation assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — miRNA targeting of GDF3 validated with reporter assay and functional cellular readout; single lab, moderate mechanistic depth\",\n      \"pmids\": [\"22223106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Macrophage PPARγ transcriptionally controls GDF3 expression in repair macrophages. GDF3 secreted by macrophages acts as an extrinsic effector on myoblasts to promote muscle progenitor cell fusion and skeletal muscle regeneration. PPARγ-null macrophages fail to upregulate GDF3, and this deficiency impairs muscle regeneration.\",\n      \"method\": \"Conditional macrophage-specific PPARγ knockout mice, muscle injury model, ChIP/transcriptional analysis, recombinant GDF3 treatment of myoblasts, fusion assay\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional knockout with defined cellular phenotype plus mechanistic identification of PPARγ as upstream regulator; replicated in subsequent studies\",\n      \"pmids\": [\"27836432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Maternal (not zygotic) Gdf3 is required for mesendoderm formation and dorsal-ventral patterning in zebrafish. Gdf3 affects left-right patterning by regulating cell morphology in Kupffer's vesicle and southpaw expression in lateral plate mesoderm. Gdf3 maternal-zygotic mutants are refractory to Nodal ligands and Lefty1 repressor, but Activin signaling and constitutively active Alk4/Alk2 remain intact, placing Gdf3 at the same pathway step as Nodal.\",\n      \"method\": \"Maternal-zygotic mutant zebrafish, RNA rescue experiments, epistasis analysis with Nodal pathway components, morphological analysis of Kupffer's vesicle\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous maternal-zygotic mutant analysis with RNA rescue and pathway epistasis in multiple developmental stages; independently replicated by companion paper\",\n      \"pmids\": [\"29140250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Gdf3 is an essential cofactor of Nodal signaling during embryonic axis establishment in zebrafish. Maternal-zygotic gdf3 mutants are fully rescued by gdf3 RNA only when co-expressed with endogenous Nodal, indicating Gdf3 acts cooperatively at the same step as Nodal ligands rather than independently. Signaling through constitutively active Alk4 and Alk2 is intact in gdf3 mutants, indicating that Gdf3 functions specifically at the Nodal pathway level.\",\n      \"method\": \"Maternal-zygotic mutant zebrafish, lineage-specific RNA targeting rescue experiments, constitutively active receptor epistasis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous genetic rescue experiments with lineage-specific targeting, epistasis analysis; independently replicated by companion paper (PMID 29140250)\",\n      \"pmids\": [\"29140249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In aged mice, repair macrophage-derived GDF3 is markedly downregulated in injured muscle compared to young mice. Supplementation of recombinant GDF3 in aged mice ameliorates the deficient regenerative response, establishing that macrophage-secreted GDF3 is functionally limiting for muscle regeneration during aging.\",\n      \"method\": \"Aged vs. young mouse muscle injury model, flow cytometry for macrophage subsets, recombinant GDF3 administration, histological analysis of regeneration\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo recombinant protein rescue experiment with defined cellular readout; single lab extending prior mechanistic work\",\n      \"pmids\": [\"30003692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GDF3 activates Smad2/Smad3 phosphorylation in macrophages and consequently inhibits NLRP3 expression, mediating anti-inflammatory effects. Recombinant GDF3 suppresses macrophage pro-inflammatory (M1) phenotype and promotes anti-inflammatory (M2) polarization. Blockade of Smad2/Smad3 phosphorylation with SB431542 offsets rGDF3-mediated anti-inflammatory effects.\",\n      \"method\": \"Recombinant GDF3 protein treatment of macrophages, Western blot for pSmad2/3, NLRP3 expression assay, pharmacological inhibition of Smad2/3 with SB431542, in vivo endotoxemia mouse model\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological epistasis linking GDF3 to Smad2/3-NLRP3 axis, supported by in vivo rescue; single lab\",\n      \"pmids\": [\"31947892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Brd4 binds to the promoter and enhancers of Gdf3 to facilitate PPARγ-dependent Gdf3 expression in macrophages. Macrophage-derived GDF3 acts as a paracrine signal on adipocytes to suppress lipase expression (ATGL, HSL) and inhibit lipolysis. Myeloid-specific Brd4 knockout reduces GDF3 in adipose tissue macrophages and increases lipolysis.\",\n      \"method\": \"ChIP-seq (Brd4 at Gdf3 locus), myeloid-specific Brd4 knockout mice, RNA-seq of adipose tissue macrophages, co-culture/conditioned medium experiments, Western blot for lipases\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq demonstrating direct Brd4 binding to Gdf3 locus, in vivo conditional knockout, and paracrine functional assay; multiple orthogonal methods\",\n      \"pmids\": [\"33830083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Recombinant GDF3 promotes macrophage phagocytosis and intracellular bacterial killing by promoting LXRα nuclear translocation. RNA-seq identified CD5L (regulated by LXRα) as the most significantly upregulated gene in rGDF3-treated macrophages. GDF3 failed to enhance bacterial uptake or killing in LXRα-knockout macrophages, placing LXRα downstream of GDF3 in this pathway.\",\n      \"method\": \"Recombinant GDF3 treatment of macrophages, RNA-seq, LXRα nuclear translocation assay, LXRα knockout macrophages, bacterial phagocytosis/killing assay, pharmacological LXRα antagonism\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (LXRα KO) and pharmacological epistasis with functional phagocytosis readout; single lab\",\n      \"pmids\": [\"33679812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GDF3 secreted by cardiac stromal PW1+ cells induces fibroblast proliferation via stimulation of activin-receptor-like kinases. GDF3 is markedly upregulated in ischemic hearts post-MI and detectable in plasma, implicating it as a paracrine cardiokine promoting adverse fibrotic remodeling.\",\n      \"method\": \"Secretome bioinformatic analysis, conditioned medium fibroblast proliferation assay, GDF3-enriched conditioned medium functional assay, activin receptor kinase pharmacological inhibition, mouse and human plasma GDF3 measurement\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — conditioned medium functional assay with receptor pharmacological epistasis; mechanistic depth is partial (receptor identity inferred from pharmacology, not genetic knockdown)\",\n      \"pmids\": [\"36484260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GDF3 is an agonist of ALK5, ALK7, ACVR2A, and ACVR2B, and an antagonist of BMPR2. Inducible GDF3 loss-of-function in obese mice reduces lipolysis by lowering β3-adrenergic receptor levels and decreasing cAMP/PKA signaling. GDF3 loss improves glucose tolerance and reduces glycemic variability without affecting body weight or energy balance.\",\n      \"method\": \"Inducible conditional knockout in adult obese mice, receptor signaling assays (ALK5/ALK7/ACVR2A/ACVR2B/BMPR2 activity), metabolic phenotyping (glucose tolerance, lipolysis, β3-AR/cAMP/PKA measurements)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo conditional knockout with multiple receptor identity assays and defined downstream signaling (β3-AR/cAMP/PKA); multiple orthogonal functional readouts\",\n      \"pmids\": [\"40360531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GDF3 promotes the inflammatory phenotype in adipose tissue macrophages through autocrine GDF3-SMAD2/3 signaling, driving chromatin accessibility toward an inflammatory state by limiting methylation-dependent chromatin compaction. Lifelong systemic or myeloid-specific Gdf3 deletion reduces endotoxemia-induced inflammation. Pharmacological inhibition of SMAD3 with SIS3 mimics Gdf3 deletion and reduces mortality from endotoxemia in old mice.\",\n      \"method\": \"Systemic and myeloid-specific Gdf3 knockout mice, scRNA-seq, ATAC-seq of ATMs, SMAD3 pharmacological inhibition (SIS3), BRD4 inhibitor (JQ1) treatment, endotoxemia mortality assay\",\n      \"journal\": \"Nature aging\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (systemic KO, myeloid-specific KO), ATAC-seq mechanistic chromatin data, pharmacological epistasis, validated in human tissue; multiple orthogonal methods in single study\",\n      \"pmids\": [\"41398392\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GDF3 is a secreted TGF-β superfamily member that functions as a BMP inhibitor (acting via its unprocessed and mature forms), an essential cofactor for Nodal signaling during embryonic axis formation (requiring Cripto co-receptor and signaling through ALK4/ALK7, ActRIIA/ActRIIB), and a pleiotropic cytokine in adult tissues where macrophage-derived GDF3 drives SMAD2/3-dependent regulation of muscle regeneration, adipose tissue lipolysis (via ALK5/ALK7/ACVR2A/ACVR2B agonism and BMPR2 antagonism suppressing β3-AR/cAMP/PKA signaling), and macrophage inflammatory phenotype by promoting chromatin accessibility toward an inflammatory state; its expression in macrophages is transcriptionally controlled upstream by PPARγ and Brd4.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GDF3 is a secreted TGF-β superfamily ligand that operates dually as a Nodal-pathway cofactor in embryonic axis formation and as a BMP inhibitor, with distinct pleiotropic roles in adult macrophages [#0, #1, #2]. During development, GDF3 antagonizes BMP signaling through both its poorly processed precursor and its mature form [#1, #4], and—acting cooperatively at the same pathway step as Nodal ligands rather than independently—signals through the EGF-CFC co-receptor Cripto and the type I/II receptors ALK4, ActRIIA and ActRIIB to drive Smad-dependent transcription [#2, #3, #10]. The native precursor is largely inactive until processed, an activity unmasked by Furin co-expression or heterologous prodomains [#3]. Together with GDF1, GDF3 is required for anterior visceral endoderm formation, mesendoderm specification, and left-right patterning, with maternal Gdf3 acting upstream of Nodal-dependent events [#3, #9, #10]. In adults, macrophage-derived GDF3 is a paracrine and autocrine cytokine: PPARγ and Brd4 drive its transcription in repair and adipose tissue macrophages [#8, #13], and secreted GDF3 promotes muscle progenitor fusion and regeneration—an output that becomes limiting with age [#8, #11]. Through SMAD2/3 signaling GDF3 suppresses adipocyte lipase expression and lipolysis, lowering β3-adrenergic receptor and cAMP/PKA signaling, and acts as an agonist of ALK5, ALK7, ACVR2A and ACVR2B while antagonizing BMPR2 [#13, #16]. Autocrine GDF3-SMAD2/3 signaling drives an inflammatory macrophage state by increasing chromatin accessibility, and its loss reduces endotoxemia-induced inflammation [#17]. Missense variants in GDF3 cause human ocular (coloboma, microphthalmia) and skeletal (Klippel-Feil) anomalies [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing GDF3 as a TGF-β superfamily member defined the structural framework—signal sequence, proteolytic processing site, and an atypical absence of the conserved intersubunit cysteine—for all later functional studies.\",\n      \"evidence\": \"cDNA cloning, sequence analysis, and Northern blot\",\n      \"pmids\": [\"8429021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional activity or receptor assigned\",\n        \"Consequences of the missing intersubunit cysteine for dimerization not tested\",\n        \"Tissue distribution of activity unknown\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying GDF3 as a physical BMP-interacting inhibitor expressed in the node established its first concrete mechanistic role in developmental patterning and stem cell state.\",\n      \"evidence\": \"Gain/loss-of-function, reporter assays, and co-IP in Xenopus and mouse ES cells\",\n      \"pmids\": [\"16339188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which BMP ligands are bound was not exhaustively mapped\",\n        \"Did not reconcile BMP-inhibitory with Nodal-like activity\",\n        \"Species-specific ES cell effects unexplained\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing GDF3 signals via Cripto and is blocked by Lefty, like Nodal, and that Gdf3-null mice have AVE defects with reduced Nodal, placed GDF3 within the Nodal signaling pathway.\",\n      \"evidence\": \"Cell reporter assays, Xenopus misexpression, mouse knockout, in situ hybridization\",\n      \"pmids\": [\"16368929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Type I/II receptor identity not resolved here\",\n        \"Relationship between Nodal-like and BMP-inhibitory activities unclear\",\n        \"Whether GDF3 signals as a ligand or cofactor unresolved\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defining ALK4/ActRIIA/ActRIIB/Cripto as the receptor module and demonstrating that the poorly-processed precursor requires Furin or prodomain swap to activate explained why native GDF3 has weak activity and unified it with GDF1 as a Vg1 homolog.\",\n      \"evidence\": \"Luciferase reporters, chimeric/Furin co-expression, Gdf1/Gdf3 compound knockout\",\n      \"pmids\": [\"17936261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological processing trigger in vivo not identified\",\n        \"Quantitative contribution of GDF1 vs GDF3 not separated\",\n        \"Mature dimer structure not determined\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolving that BMP inhibition occurs at physiological doses via both precursor and mature forms, while Nodal activation requires non-physiological overexpression, clarified GDF3's predominant in vivo activity.\",\n      \"evidence\": \"mRNA vs recombinant protein dose-response reporter assays, Western blot of protein forms\",\n      \"pmids\": [\"18823971\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Context determining BMP-inhibition vs Nodal-cofactor role unclear\",\n        \"Mechanism by which the precursor inhibits BMP not defined\",\n        \"In vivo dose dependence not directly measured\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking GDF3 missense variants to human ocular and skeletal malformations, with zebrafish knockdown phenocopy, established GDF3 as necessary for human eye and axial skeletal development.\",\n      \"evidence\": \"Patient variant Western blot/reporter assays and zebrafish morpholino knockdown\",\n      \"pmids\": [\"19864492\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism linking signaling defect to specific malformations not detailed\",\n        \"Penetrance and genotype-phenotype correlation limited\",\n        \"Morpholino specificity caveats\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating ALK7 association in a Cripto-dependent manner and GDF3-driven neuronal differentiation extended its receptor repertoire and suggested non-developmental cellular effects.\",\n      \"evidence\": \"Co-IP receptor association, conditioned medium on PC12/neurons, immunofluorescence\",\n      \"pmids\": [\"21805089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Cripto-dependence not fully characterized\",\n        \"Conditioned medium lacked protein quantification\",\n        \"Physiological relevance of neuronal effect untested in vivo\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying miR-483-3p as a translational repressor of GDF3 revealed post-transcriptional control of GDF3 in adipocyte differentiation and lipid storage.\",\n      \"evidence\": \"miRNA overexpression/knockdown, luciferase target validation, adipocyte assays\",\n      \"pmids\": [\"22223106\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Fraction of phenotype attributable to GDF3 vs other targets unclear\",\n        \"In vivo regulation not demonstrated\",\n        \"Downstream signaling not mapped\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing PPARγ transcriptionally drives macrophage GDF3, which acts on myoblasts to promote fusion and regeneration, established GDF3 as a macrophage-derived effector of tissue repair.\",\n      \"evidence\": \"Macrophage-specific PPARγ knockout, muscle injury model, recombinant GDF3 fusion assay\",\n      \"pmids\": [\"27836432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Receptor on myoblasts not identified here\",\n        \"Direct vs indirect fusion mechanism unresolved\",\n        \"Whether developmental and repair pathways share components unknown\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that macrophage GDF3 declines with age and that recombinant supplementation restores regeneration established GDF3 as a functionally limiting factor in aged muscle repair.\",\n      \"evidence\": \"Aged vs young muscle injury, macrophage flow cytometry, recombinant GDF3 rescue\",\n      \"pmids\": [\"30003692\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Cause of age-related downregulation not identified\",\n        \"Single-lab extension of prior work\",\n        \"Receptor/signaling in aged myoblasts not dissected\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linking GDF3 to Smad2/3-dependent NLRP3 suppression and M2 polarization defined a signaling axis for its anti-inflammatory macrophage effects.\",\n      \"evidence\": \"Recombinant GDF3, pSmad2/3 Western, NLRP3 assays, SB431542 inhibition, endotoxemia model\",\n      \"pmids\": [\"31947892\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Anti-inflammatory effect here conflicts with later pro-inflammatory role\",\n        \"Specific receptor mediating Smad2/3 in macrophages not defined\",\n        \"Single lab\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying Brd4 binding at the Gdf3 locus to enable PPARγ-dependent expression, and the resulting paracrine suppression of adipocyte lipases, mapped both upstream control and a metabolic output of macrophage GDF3.\",\n      \"evidence\": \"ChIP-seq, myeloid Brd4 knockout, RNA-seq, conditioned medium, lipase Westerns\",\n      \"pmids\": [\"33830083\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Adipocyte receptor mediating lipase suppression not pinpointed here\",\n        \"Relationship between PPARγ and Brd4 cooperativity not fully defined\",\n        \"Systemic metabolic consequences not yet tested\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placing LXRα/CD5L downstream of GDF3 in promoting macrophage phagocytosis and bacterial killing identified a distinct antimicrobial effector arm.\",\n      \"evidence\": \"Recombinant GDF3, RNA-seq, LXRα translocation, LXRα knockout, phagocytosis assays\",\n      \"pmids\": [\"33679812\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Receptor coupling GDF3 to LXRα not defined\",\n        \"In vivo infection relevance limited\",\n        \"Single lab\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showing cardiac PW1+ cell-derived GDF3 drives fibroblast proliferation via activin-like kinases after infarction extended its paracrine role to adverse cardiac fibrotic remodeling.\",\n      \"evidence\": \"Secretome analysis, conditioned medium proliferation, receptor pharmacology, plasma GDF3\",\n      \"pmids\": [\"36484260\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Receptor identity inferred pharmacologically, not by genetic knockdown\",\n        \"Causal in vivo role of cardiac GDF3 not established by loss-of-function\",\n        \"Single lab\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defining GDF3 as an ALK5/ALK7/ACVR2A/ACVR2B agonist and BMPR2 antagonist, and showing inducible loss reduces lipolysis via β3-AR/cAMP/PKA while improving glucose tolerance, provided the adult receptor logic and metabolic consequences of GDF3 signaling.\",\n      \"evidence\": \"Inducible conditional knockout in obese mice, receptor signaling assays, metabolic phenotyping\",\n      \"pmids\": [\"40360531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How agonist/antagonist activities are balanced on individual cells unclear\",\n        \"Tissue source of the active GDF3 in this context not fully resolved\",\n        \"Human translatability untested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating that autocrine GDF3-SMAD2/3 signaling drives an inflammatory macrophage state through increased chromatin accessibility, and that Gdf3 deletion or SMAD3 inhibition reduces endotoxemia, reframed GDF3 as a pro-inflammatory chromatin regulator in aging.\",\n      \"evidence\": \"Systemic/myeloid Gdf3 knockout, scRNA-seq, ATAC-seq, SIS3 and JQ1 treatment, endotoxemia mortality\",\n      \"pmids\": [\"41398392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Reconciliation with the earlier anti-inflammatory/NLRP3-suppressive report needed\",\n        \"Molecular link between SMAD2/3 and chromatin compaction machinery not fully defined\",\n        \"Receptor mediating autocrine signaling not specified\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown what determines the context-dependent switch between GDF3's BMP-inhibitory, Nodal-cofactor, and SMAD2/3-agonist activities, and how the same ligand produces opposing pro- and anti-inflammatory outcomes in macrophages.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No unifying model reconciles agonist vs inhibitor behavior across tissues\",\n        \"Structural basis of GDF3 dimerization and receptor selectivity undefined\",\n        \"In vivo processing/activation triggers not identified\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [2, 3, 6, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 16]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 12, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 6, 8, 13, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 12, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 3, 5, 9, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [12, 14, 17]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 13, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TDGF1\",\n      \"ACVR1B\",\n      \"ACVR2A\",\n      \"ACVR2B\",\n      \"ACVR1C\",\n      \"TGFBR1\",\n      \"BMPR2\",\n      \"BMP\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}